Schonfeld Strategic Advisors LLC Ideaya Biosciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$34.2 - $47.13 $285,672 - $393,676
-8,353 Reduced 26.34%
23,354 $1.02 Million
Q4 2023

Feb 14, 2024
SELL
$24.59 - $35.83 $28,057 - $40,882
-1,141 Reduced 3.47%
31,707 $1.13 Million
Q3 2023

Nov 14, 2023
SELL
$21.07 - $29.77 $747,753 - $1.06 Million
-35,489 Reduced 51.93%
32,848 $886,000
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $253,429 - $485,376
19,012 Added 38.54%
68,337 $1.61 Million
Q1 2023

May 15, 2023
BUY
$13.49 - $18.72 $665,394 - $923,364
49,325 New
49,325 $677,000

Others Institutions Holding IDYA

# of Institutions
216
Shares Held
80.8M
Call Options Held
69K
Put Options Held
20K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.28B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email